본문 바로가기
KERD
논문KCI 등재

양성 성대 병변에 대한 성대내 스테로이드 주사치료

Intralesional Steroid Injection Therapy of the Benign Vocal Fold Lesions

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Voice therapy and laryngeal microsurgery are the main treatment options for benign vocal fold lesions. However, if patients are unable to endure lengthy voice therapy, or refuse surgery under general anesthesia, clinicians need to try other methods. Recently local steroid injection directly into the true vocal folds (TVF) benign lesions has been focused on alternative treatment options, and good results have been reported. Local steroid injection into the TVF was first described in 1964 by Dr. Yanagihara. Although this initial technique was inaccurate, however, with the advancement of modern endoscopy, recent emerging articles have proposed for the effectiveness of in-office awake vocal fold steroid injection in the treatment of benign vocal fold lesions. Based on previous studies of vocal fold steroid injection in the treatment of benign vocal fold lesions, I will summarize and suggest as follows. Various corticosteroids (triamcinolone acetonide, methylprednisolone, dexamethasone sodium phosphate) are used for the intralesional injection in the treatment of benign vocal fold lesions. The steroid injection approach can be transoral, transcutaneous or via flexible endoscope with operating channel, and injection route depends mainly on availability and individual experience. Intralesional corticosteroid injection significantly reduces benign vocal fold lesion volume and improves voice quality, at least transiently. There are many unresolved issues remain regarding the problem of vocal fold atrophy after steroid injection. Nevertheless, to minimize the risk of vocal atrophy, it is advisable to pay attention to repeating short interval steroid injection or administrating high dose of steroid. And, in case where repeated steroid injections are necessary for benign vocal fold lesions such as vocal nodule, vocal polyp, Reinke’s edema, I suggest that 12 weeks intervals would be safe to prevent vocal fold atrophy. And, to prevent recurrence of benign vocal fold lesions after steroid injection therapy, it is recommended to add post-procedural voice therapy, including vocal hygiene.

Abstract

Voice therapy and laryngeal microsurgery are the main treatment options for benign vocal fold lesions. However, if patients are unable to endure lengthy voice therapy, or refuse surgery under general anesthesia, clinicians need to try other methods. Recently local steroid injection directly into the true vocal folds (TVF) benign lesions has been focused on alternative treatment options, and good results have been reported. Local steroid injection into the TVF was first described in 1964 by Dr. Yanagihara. Although this initial technique was inaccurate, however, with the advancement of modern endoscopy, recent emerging articles have proposed for the effectiveness of in-office awake vocal fold steroid injection in the treatment of benign vocal fold lesions. Based on previous studies of vocal fold steroid injection in the treatment of benign vocal fold lesions, I will summarize and suggest as follows. Various corticosteroids (triamcinolone acetonide, methylprednisolone, dexamethasone sodium phosphate) are used for the intralesional injection in the treatment of benign vocal fold lesions. The steroid injection approach can be transoral, transcutaneous or via flexible endoscope with operating channel, and injection route depends mainly on availability and individual experience. Intralesional corticosteroid injection significantly reduces benign vocal fold lesion volume and improves voice quality, at least transiently. There are many unresolved issues remain regarding the problem of vocal fold atrophy after steroid injection. Nevertheless, to minimize the risk of vocal atrophy, it is advisable to pay attention to repeating short interval steroid injection or administrating high dose of steroid. And, in case where repeated steroid injections are necessary for benign vocal fold lesions such as vocal nodule, vocal polyp, Reinke’s edema, I suggest that 12 weeks intervals would be safe to prevent vocal fold atrophy. And, to prevent recurrence of benign vocal fold lesions after steroid injection therapy, it is recommended to add post-procedural voice therapy, including vocal hygiene.

참고문헌 (9)

  1. Wang CT, "Intralesional steroid injection for benign vocal fold disorders : a systematic review and meta-analysis", Laryngoscope, 123(1), pp.197~203 (2013)
  2. Dassé R, "First-line treatment of exudative vocal fold-lesions by in-office local corticosteroid injection : a literature review", Eur Ann Otorhinolaryngol Head Neck Dis, 138(3), pp.169~175 (2021)
  3. Tateya I, "Laryngeal steroid injection", Curr Opin Otolaryngol Head Neck Surg, 17(6), pp.424~426 (2009)
  4. Lee SW, "Long-term efficacy of percutaneous steroid injection for treating benign vocal fold lesions : a prospective study", Laryngoscope, 126(10), pp.2315~2319 (2016)
  5. Wang CT, "Long-term surveillance following intralesional steroid injection for benign vocal fold lesions", JAMA Otolaryngol Head Neck Surg, 143(6), pp.589~594 (2017)
  6. Lee SH, "Local steroid injection via the cricothyroid membrane in patients with a vocal nodule", Arch Otolaryngol Head Neck Surg, 137(10), pp.1011~1016 (2011)
  7. Jin HJ, "Morphological and histological changes of rabbit vocal fold after steroid injection", Otolaryngol Head Neck Surg, 149(2), pp.277~283 (2013)
  8. Hashimoto K, "Effects of repeated intracordal glucocorticoid injection on the histology and gene expression of rat vocal folds", J Voice, 37(6), pp.822~828 (2023)
  9. Mortensen M, "Office steroid injections of the larynx", Laryngoscope, 116(10), pp.1735~1739 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (5건)